Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses

New venture aligns with Jaguar’s mental health Entheogen Therapeutics Initiative (ETI) and Filament’s corporate mission to develop novel, natural prescription medicines from plants Magdalena Biosciences will leverage Jaguar’s proprietary medicinal plant library and Filament’s proprietary drug development technology Magdalena Biosciences is currently valued at US$5.0 million based on initial and…

Source